49 / 220
47
Pharmaceuticals and Aromatics – I
Product groups: API intermediates, Active Pharmaceutical Ingredients, Others
The products falling under these product groups are used by customers belonging to Pharmaceutical industry for various
therapeutic categories, such as anti-depressant, anti-diabetic, anti-infective, anti-retroviral and cardiovascular. The product
groups comprise about 72 products. Carbonates, chloroformates, isocyanates and organic ureas are some of the key classes
of products.
During 2017-18, sales increased by 7% from
`
342 cr
to
`
367 cr. Sales in India increased by 22% from
`
178 cr to
`
218 cr. Sales outside India decreased by 9% from
`
164 cr
to
`
149 cr and formed 41% of the total. Growth on account
of volume was 6%. The Company completed 1 project and
undertook 1 project for implementation. Atul Bioscience Ltd
(ABL), a 100% subsidiary company, focused on production of
advanced API intermediates, increased its sales by 33% from
`
57 cr to
`
76 cr, primarily because of volume; it undertook
2 debottlenecking projects for implementation.
The size of the world Pharmaceutical industry is estimated
at US$ 1.75 tn, of which the conventional pharmaceutical
segment is estimated to be US$ 1.3 tn. Of this, the size
of the world API industry is estimated to be US$ 160 bn.
There are about 20 major
companies which dominate the
world marketplace.
The main user industry, namely,
Pharmaceutical, is growing well
because of increasing awareness
about diseases and health. The
Company along with ABL will
participate in this growth by i)
widening its market reach, ii)
increasing its manufacturing
efficiencies, iii) generating and
adding capacities, iv) introducing
new products and v) forming
long-term strategic alliances
with other companies.
The prices of some products
may come down in a short time.
Fluctuations in foreign exchange
may impact sales realisations.